MaxCyte

$4.82 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About MaxCyte

MaxCyte, Inc. provides laboratory testing and research services. The Company offers processing assemblies, protein production, cell analysis, and antibodies research services. MaxCyte conducts its business in the United States.

Stock Analysis

last close $5.25
1-mo return 12.4%
3-mo return -23.9%
avg daily vol. 737.91T
52-week high 17.44
52-week low 3.36
market cap. $511M
forward pe -
annual div. -
roe -12.7%
ltg forecast -
dividend yield -
annual rev. $25M
inst own. 84.6%
baraka

Subscribe now for daily local and international financial news

Subscribe